Evidence map›Paper›PMID 40487343›Full record

ArticleAmerican journal of ophthalmology case reports2025

Acute myeloid leukemia presenting as an isolated orbital mass in an adult.

Cindy S Zhao, Lin Wang, Joshua R Menke, Natalie A Homer

Abstract readCase Reports
In one paragraph

Article in American journal of ophthalmology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Cindy S ZhaoByers Eye Institute at Stanford University, 2452 Watson Ct, Palo Alto, CA, 94303, USA.
Lin WangStanford University Department of Pathology, Lane Building L235, 300 Pasteur Drive, Stanford, CA, 94305, USA.
Joshua R MenkeStanford University Department of Pathology, Lane Building L235, 300 Pasteur Drive, Stanford, CA, 94305, USA.
Natalie A HomerByers Eye Institute at Stanford University, 2452 Watson Ct, Palo Alto, CA, 94303, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Myeloid sarcoma (MS) is an extramedullary-based hematolymphoid tumor that presents in 2-9 % of cases of acute myeloid leukemia (AML). Observations: A 61-year-old man presented with several weeks of unilateral eye pain, proptosis, and diplopia. Examination demonstrated 4 mm of proptosis with limitation of supraduction and abduction. Presenting visual acuity was 20/50 with no signs of optic neuropathy. Imaging revealed an infiltrative, retrobulbar soft tissue density involving the extraocular muscles and optic nerve. Laboratory workup for inflammatory and infectious etiologies was negative. The patient initially responded well to a high-dose oral steroid taper but developed recurrent symptoms. Biopsy was pursued and histopathology was consistent with MS, conferring a diagnosis of AML. Oncologic workup demonstrated central nervous system involvement. After orbital radiation and chemotherapy, no further blasts were detectable in the cerebral spinal fluid. At one year follow-up the patient had complete clinical tumor regression, with stable visual acuity and resolved right exophthalmos. Conclusions and importance: In adults, MS presents rarely as an isolated finding in the orbit. Biopsy is indicated when an orbital mass recurs or does not fully respond to anti-inflammatory treatment. Establishing a diagnosis of MS can be a histopathological challenge. Genetic testing to evaluate for CEBPA mutations in the bZIP domain can predict a good prognosis.

Indexed as

Acute myeloid leukemiaGranulocytic sarcomaMyeloid sarcomaOrbital massOrbital neoplasm

Identifiers

PMID40487343
PMCPMC12144496

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.